SCHEMBL25333984

SCHEMBL25333984

CC(=O)C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC(O)[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.67
LMNA P02545 6/20 0.67
SERPINA6 P08185 6/20 0.67
SMN1; SMN2 Q16637 5/20 0.67
TSHR P16473 4/20 0.67
MAPT P10636 4/20 0.67
MAPK1 P28482 4/20 0.67
ALDH1A1 P00352 4/20 0.67
GPBAR1 Q8TDU6 4/20 0.67
SHBG P04278 4/20 0.67
NR3C1 P04150 3/20 0.67
PGR P06401 3/20 0.67
AR P10275 3/20 0.67
SIGMAR1 Q99720 3/20 0.67
CYP2C9 P11712 2/20 0.67
HIF1A Q16665 2/20 0.67
NR3C2 P08235 2/20 0.67
ABCB11 O95342 2/20 0.67
CYP2C19 P33261 1/20 0.67
KDM4E B2RXH2 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661927 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL3509140 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL5436459 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL8069 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL1457788 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL571703 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL4747200 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
SCHEMBL2724646 1.00 CYP3A4 (0.67) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
Hydrochloric Acid SCHEMBL3198033 0.99 CYP3A4 (0.66) CYP3A4LMNASERPINA6SMN1; SMN2TSHR
Bicarbonate SCHEMBL6684636 0.98 CYP3A4 (0.65) CYP3A4LMNASERPINA6SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250131-A1 HYDROXYSTEROID COMPOUNDS EPIRIUM BIO INC (US) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250131-A1 HYDROXYSTEROID COMPOUNDS HSD3B2, HSD11B1, HSD3B1 CYP3A4 132/4885LMNA 2148/4885SERPINA6 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.